The Second Laminin G-type Domain of Protein S Is Indispensable for Expression of Full Cofactor Activity in Activated Protein C-catalysed Inactivation of Factor Va and Factor VIIIa

 

 Buy Article Permissions and Reprints

Summary

Vitamin K-dependent protein S is a cofactor to the anticoagulant serine protease activated protein C (APC) in the proteolytic inactivation of the procoagulant, activated factor V (FVa) and factor VIII (FVIIIa). In the FVa degradation, protein S selectively accelerates the cleavage at Arg306, having no effect on the Arg506 cleavage. In the FVIIIa inactivation, the APC-cofactor activity of protein S is synergistically potentiated by FV, which thus has the capacity to function both as a pro- and an anticoagulant protein. The SHBG-like region of protein S, containing two laminin G-type domains, is required for the combined action of protein S and FV. To elucidate whether both G domains in protein S are needed for expression of APC-cofactor activities, chimeras of human protein S were created in which the individual G domains were replaced by the corresponding domain of the homologous Gas6, which in itself has no anticoagulant activity. In a plasmabased assay, chimera I (G1 from Gas6) was as efficient as wild-type recombinant protein S, whereas chimera II (G2 from Gas6) was less effective. The synergistic cofactor activity with FV in the inactivation of FVIIIa was lost by the replacement of the G2 domain in protein S (chimera II). However, chimera I did not exert full APC-cofactor activity in the FVIIIa degradation, indicating involvement of both G domains or the entire SHBG-like region in this reaction. Chimera I was fully active in the degradation of FVa in contrast to chimera II, which exhibited reduced cofactor activity compared to protein S. In conclusion, by using protein S-Gas6 chimeric proteins, we have identified the G2 domain of protein S to be indispensable for an efficient inactivation of both FVIIIa and FVa, whereas the G1 domain was found not to be of direct importance in the FVa-inactivation experiments.

• References

• 1 Tans G, Nicolaes GAF, Rosing J. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation. Semin Hematol 1997; 34: 244-55.
  PubMedGoogle Scholar
• 2 Dahlbäck B, Stenflo J. The Protein C anticoagulant system. In: Stammatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H. eds. WB Saunders company; Molecular Basis of Blood Disease. Third ed. Philadelphia: 2000. in press.
  Google Scholar
• 3 Rosing J, Hoekema L, Nicolaes GAF, Thomassen MCLGD, Hemker HC, Váradi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-8.
  CrossrefPubMedGoogle Scholar
• 4 Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994; 269: 18735-8.
  PubMedGoogle Scholar
• 5 Lu D, Kalafatis M, Mann KG, Long GL. Comparison of activated protein C/ protein S-mediated inactivation of human factor VIII and factor V. Blood 1996; 87: 4708-17.
  PubMedGoogle Scholar
• 6 Walker FJ, Chavin SI, Fay PJ. Inactivation of FVIIIa by activated protein C and protein S. Arch Biochem Biophys 1987; 252: 322-8.
  CrossrefPubMedGoogle Scholar
• 7 Váradi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of FVIII: Influence of the Factor VR506Q mutation. Thromb Haemost 1996; 76: 208-14.
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-80.
  PubMedGoogle Scholar
• 9 Nicolaes GAF, Tans G, Thomassen MCLGD, Hemker HC, Pabinger I, Váradi K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 21158-66.
  CrossrefPubMedGoogle Scholar
• 10 Lundwall Å, Dackowski W, Cohen E, Shaffer M, Mahr A, Dahlbäck B, Stenflo J, Wydro R. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci U.S.A 1986; 83: 6716-20.
  CrossrefPubMedGoogle Scholar
• 11 Gershagen S, Fernlund P, Lundwall Å. A cDNA coding for human sex hormone binding globulin. Homology to vitamin K-dependent protein S. FEBS Letters 1987; 220: 129-35.
  PubMedGoogle Scholar
• 12 Joseph DR, Baker ME. Sex hormone-binding globulin, androgen-binding protein, and vitamin K-dependent protein S are homologous to laminin A, merosin, and Drosophila crumbs protein. FASEB 1992; 06: 2477-81.
  CrossrefPubMedGoogle Scholar
• 13 Villoutreix BO, García de Frutos P, Lövenklev M, Linse S, Fernlund P, Dahlbäck B. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism, spectroscopy, and analysis of naturally occurring mutations. Proteins 1997; 29: 478-91.
  CrossrefPubMedGoogle Scholar
• 14 Talts JF, Mann K, Yamada Y, Timpl R. Structural analysis and proteolytic processing of recombinant G domain of mouse laminin α2 chain. FEBS Letters 1998; 426: 71-6.
  CrossrefPubMedGoogle Scholar
• 15 Aiach M, Borgel D, Gaussem P, Emmerich J, Alhenc-Gelas M, Gandrille S. Protein C and protein S deficiencies. Semin Hematol 1997; 34: 205-17.
  PubMedGoogle Scholar
• 16 Walker FJ. Regulation of protein C by protein S: The role of phospholipid in FVa inactivation. J Biol Chem 1981; 256: 11128-31.
  PubMedGoogle Scholar
• 17 Yegneswaran S, Wood GM, Esmon CT, Johnson AE. Protein S alters the active site location of activated protein C above the membrane. J Biol Chem 1997; 272: 25013-21.
  CrossrefPubMedGoogle Scholar
• 18 Dahlbäck B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 1990; 265: 8127-35.
  PubMedGoogle Scholar
• 19 He X, Shen L, Dahlbäck B. Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein Sdefining modules important for the species specificity of the activated protein C cofactor activity. Eur J Biochem 1995; 227: 433-40.
  CrossrefPubMedGoogle Scholar
• 20 He X, Shen L, Villoutreix BO, Dahlbäck B. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem 1998; 273: 27449-58.
  CrossrefPubMedGoogle Scholar
• 21 Nyberg P, Dahlbäck B, García de Frutos P. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. FEBS Letters 1998; 433: 28-32.
  CrossrefPubMedGoogle Scholar
• 22 Koppelman SJ, van’t Veer C, Sixma JJ, Bouma BN. Inhibition of the intrinsic factor X activation by protein S: Evidence for a specific binding of protein S to factor VIII. Blood 1995; 86: 2653-60.
  PubMedGoogle Scholar
• 23 Mitchell CA, Kelemen SM, Salem HH. The anticoagulant properties of a modified form of protein S. Thromb. Haemost 1988; 60: 298-304.
  Article in Thieme ConnectPubMedGoogle Scholar
• 24 Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988; 54: 787-93.
  CrossrefPubMedGoogle Scholar
• 25 Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin Kdependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993; 13: 4976-85.
  CrossrefPubMedGoogle Scholar
• 26 Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 1996; 12: 471-80.
  PubMedGoogle Scholar
• 27 McCloskey P, Friedell Y-W, Attar E, Villa J, Jin Y, Varnum B, Liu ET. Gas6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem 1997; 272: 23285-91.
  CrossrefPubMedGoogle Scholar
• 28 Varnum BC, Young C, Elliott G, Garcia A, Bartley TD, Fridell YW, Hunt RW, Trail G, Clogson C, Toso RJ, Yanagihara D, Bennett L, Sylber M, Merewether LA, Tseng A, Escobar E, Liu ET, Yamane HK. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 1995; 373: 623-6.
  CrossrefPubMedGoogle Scholar
• 29 Godowski PJ, Mark MR, Chen J, Sadick MD, Raab H, Hammonds RG. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995; 82: 355-8.
  CrossrefPubMedGoogle Scholar
• 30 Chen J, Carey K, Godowski PJ. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 1997; 14: 2033-9.
  CrossrefPubMedGoogle Scholar
• 31 Rosing J, Bakker HM, Thomassen MCLGD, Hemker HC, Tans G. Characterization of two forms of human FVa with different cofactor activities. J Biol Chem 1993; 268: 21130-6.
  PubMedGoogle Scholar
• 32 Persson E, Hogg PJ, Stenflo J. Effects of Ca2+ binding on the protease module of factor Xa and its interaction with factor Va. Evidence for two Gla-independent Ca(2+)-binding sites in factor Xa. J Biol Chem 1993; 268: 22531-9.
  PubMedGoogle Scholar
• 33 Evenäs P, García de Frutos P, Linse S, Dahlbäck B. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem 1999; 266: 935-42.
  CrossrefPubMedGoogle Scholar
• 34 Thorelli E, Kaufman RJ, Dahlbäck B. Cleavage of factor V at Arg506 by activated protein C and the expression of anticoagulant activity of factor V. Blood 1999; 93: 2552-8.
  PubMedGoogle Scholar
• 35 Kaufman RJ. Vectors used for expression in mammalian cells. Methods Enzymol 1990; 185: 487-511.
  PubMedGoogle Scholar
• 36 Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-7.
  PubMedGoogle Scholar
• 37 Tans G, Rosing J, Thomassen MCLGD, Heeb MJ, Zwaal RFA, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641-8.
  PubMedGoogle Scholar
• 38 Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
  PubMedGoogle Scholar
• 39 Malm J, Cohen E, Dackowski W, Dahlbäck B, Wydro R. Expression of completely γ-carboxylated and β-hydroxylated recombinant human vitamin K-dependent protein S with full biological activity. Eur J Biochem 1990; 187: 737-43.
  CrossrefPubMedGoogle Scholar
• 40 Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
  PubMedGoogle Scholar
• 41 Egan JO, Kalafatis M, Mann KG. The effect of Arg306→Ala and Arg506→Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. Protein Sci 1997; 06: 2016-27.
  CrossrefPubMedGoogle Scholar
• 42 Heeb MJ, Rehemtulla A, Moussali M, Kojima Y, Kaufman RJ. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation. Eur J Biochem 1999; 260: 64-75.
  CrossrefPubMedGoogle Scholar
• 43 Deutzmann R, Huber H, Schmelz KA, Oberbäumer I, Hatl L. Structural study of long arm fragments of laminin. Evidence for repetitive C-terminal sequences in the A-chain, not present in the B-chains. Eur J Biochem 1988; 177: 35-45.
  CrossrefPubMedGoogle Scholar
• 44 Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassel JR. The complement sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, LDL-receptor and N-CAM. J Biol Chem 1991; 266: 22939-47.
  PubMedGoogle Scholar
• 45 Rothberg JM, Artavanis-Tsakonas S. Modularity of the slit protein. Characterization of a conserved carboxy-terminal sequence in secreted proteins and a motif implicated in extracellular protein interactions. J Mol Biol 1992; 227: 367-70.
  CrossrefPubMedGoogle Scholar
• 46 Ushkaryov YA, Petrenko AG, Geppert M, Südhof TC. Neurexins: Synaptic cell surface proteins related to the α-lactrotoxin receptor and laminin. Science 1992; 257: 50-6.
  CrossrefPubMedGoogle Scholar
• 47 Beckmann G, Hanke J, Bork P, Reich JG. Merging extracellular domains: Fold prediction for laminin G-like amino-terminal thrombospondin-like modules based on homology to pentraxins. J Mol Biol 1998; 275: 725-30.
  CrossrefPubMedGoogle Scholar
• 48 He X, Shen L, Malmborg A-C, Smith KJ, Dahlbäck B, Linse S. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin G-type-repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance. Biochemistry 1997; 36: 3745-54.
  CrossrefPubMedGoogle Scholar
• 49 Evenäs P, Dahlbäck B, García de Frutos P. The first laminin G-type domain in the SHBG-like region of protein S contains residues essential for activation of the receptor tyrosine kinase Sky. Biol Chem 2000; 381: 199-209.
  PubMedGoogle Scholar
• 50 Rudenko G, Nguyen T, Chelliah Y, Südhof TC, Deisenhofer J. The structure of the ligand-binding domain of Neurexin Ib: Regulation of LNS domain function by alternative splicing. Cell 1999; 99: 93-101.
  CrossrefPubMedGoogle Scholar